SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Dexxon Holdings Ltd. (Last) (First) (Middle) 1 DEXCEL STREET (Street) OR AKIVA L3 30600000 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 03/04/2015	3. Issuer Name and Ticker or Trading Symbol TEKMIRA PHARMACEUTICALS Corp [ TKMR ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	16,013,540(1)	I	See footnote(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* Dexxon Holdings Ltd. (Last) (First) (Middle) 1 DEXCEL STREET (Street) OR AKIVA L3 30600000 (City) (State) (Zip)

1. Name and Address of Reporting Person* Oren Dan (Last) (First) (Middle) 1 DEXCEL STREET (Street) OR AKIVA L3 30600000 (City) (State) (Zip)

Explanation of Responses:

1. Dexxon Holdings Ltd. ("Dexxon") may be deemed to have investment and voting control over the 16,013,540 common shares of Tekmira Pharmaceuticals Corporation held by Roivant Sciences Ltd. ("Roivant"). Voting and dispositive decisions of Dexxon are made by its sole director, Dan Oren, and Dan Oren may also be deemed to have investment and voting control over the shares held by Roivant. The filing of this statement shall not be deemed an admission that either Dexxon or Mr. Oren is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of Dexxon and Mr. Oren expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.

Remarks:

	/s/ Alison Haggerty, Attorney-in-Fact	03/16/2015
	/s/Alison Haggerty, Attorney-in-Fact	03/16/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

POWER OF ATTORNEY
(For Executing Form ID and Forms 3, 4 and 5)

Know all by these presents that the undersigned hereby constitutes and appoints
each of Div Gupta and Alison Haggerty of Cooley LLP, signing individually, the
undersigned's true and lawful attorney-in-fact and agents to:

(1)	Prepare, execute in the undersigned's name and on the undersigned's behalf,
and submit to the Securities and Exchange Commission (the "SEC") a Form ID,
including amendments thereto, and any other documents necessary or appropriate
to obtain codes and passwords enabling the undersigned to make electronic
filings with the SEC of reports required by Section 16(a) of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), or any rule or regulation
thereunder;

(2)	Prepare, execute in the undersigned's name and on the undersigned's behalf,
and submit to the SEC Forms 3, 4 and 5 (including amendments thereto and joint
filing agreements in connection therewith) in accordance with Section 16(a) of
the Exchange Act and the rules thereunder;

(3)	Do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to prepare, complete and execute any such Form 3,
4 or 5 (including amendments thereto and joint filing agreements in connection
therewith) and timely file such forms with the SEC and any stock exchange,
self-regulatory association or any other authority; and

(4)	Take any other action of any type whatsoever in connection with the
foregoing that, in the opinion of any such attorney-in-fact, may be necessary or
desirable in connection with the foregoing authority, it being understood that
the documents executed by any such attorney-in-fact on behalf of the undersigned
pursuant to this Power of Attorney shall be in such form and shall contain such
terms and conditions as the attorney-in-fact may approve in the
attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in- fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein
granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, and
their substitutes, in serving in such capacity at the request of the
undersigned, are not assuming any of the undersigned's responsibilities to
comply with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5, unless earlier
revoked by the undersigned in a signed writing delivered to the
attorneys-in-fact or, as to any attorney-in-fact individually, such
attorney-in-fact is no longer affiliated with Cooley LLP, as applicable.  This
Power of Attorney revokes any other power of attorney that the undersigned has
previously granted to representatives of Cooley LLP.  This Power of Attorney may
be filed with the SEC as a confirming statement of the authority granted herein.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of the date written below.

Dated:  March 16, 2015

Dexxon Holdings Ltd.

By:	/s/Dan Oren
Name:   Dan Oren
Title:  Director

Dated:  March 16, 2015
/s/Dan Oren
Dan Oren